TAG:
laboratory company
AML & Dynacare Next To Try a Public Offering
By Robert Michel | From the Volume VII No. 15 – October 23, 2000 Issue
CEO SUMMARY: There will be plenty of competition for investors’ dollars this fall. American Medical Laboratories and Dynacare will join Specialty Laboratories in the effort to place an initial public offering (IPO). Three laboratory companies coming to market during the same period will…
IPO Is Major Strategy For American Med Labs
By Robert Michel | From the Volume VII No. 15 – October 23, 2000 Issue
CEO SUMMARY: Since its acquisition in 1997, American Medical Laboratories’ fast growth was funded by heavy borrowing. Now this Virginia-based lab company needs to raise additional capital so it can restructure its debt and lay a foundation for the next cycle of growth. Its initial publi…
ISO 9000 Growing Across Lab Divisions of Quest Diagnostics
By Robert Michel | From the Volume VII No. 15 – October 23, 2000 Issue
CEO SUMMARY: Currently the American healthcare system is struggling to evolve away from its “cottage industry” roots and adopt modern corporate management methods. Within the clinical laboratory industry, Quest Diagnostics Incorporated has staked out the high ground. Its strategic obj…
Dynacare Sets Sights On Raising $89 Million
By Robert Michel | From the Volume VII No. 15 – October 23, 2000 Issue
CEO SUMMARY: Throughout the 1990s, Dynacare weathered the wholesale restructuring of health services in several key Canadian provinces where it operates. In the United States, it sought to build a national base of lab testing even as lab consolidation raged and capitated managed care cont…
Specialty Labs Prepares For Public Stock Offering
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: Stock prices for public lab companies zoomed upwards through 2000. For this reason, executives at Specialty Laboratories, Inc. believe it is an auspicious time for their laboratory to bring an initial public offering (IPO) to market. Company officials recently filed a stock r…
Successful Specialty IPO Can Open Door for Others
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: It’s no secret that a handful of laboratory companies would like to complete an initial public offering (IPO). If Specialty Labs’ public offering goes well, expect these lab companies to bring their own stock offerings to the public equity markets. As the number of public…
Bill Bonello Sees Opportunities In Diagnostic Services Companies
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: With the clinical laboratory industry now enjoying growing interest by professional investors, THE DARK REPORT traveled to New York City to meet with financial analyst William B. Bonello, of U S Bancorp Piper Jaffray. Bonello co-authored a just-released overview of what he ca…
Is it Early-90s “Deja Vu” For Today’s Lab Industry?
By Robert Michel | From the Volume VII No. 14 – October 2, 2000 Issue
CEO SUMMARY: Stock prices for laboratory and pathology companies have skyrocketed since the new decade of the 2000s dawned on January 1. Is investor optimism warranted by the opportunities ahead in diagnostic testing? Or will history repeat itself if the continuing evolution of American h…
Quest Diagnostics Emphasizes Venture Capital Investments
By Robert Michel | From the Volume VII No. 13 – September 11, 2000 Issue
ONE SIGNIFICANT business strategy in play at Quest Diagnostics Incorporated is venture capital investing. With $3 billion in sales, Quest Diagnostics is the largest clinical laboratory company in the United States. It understands that the traditional lab sales strategy of marketing …
“August 21, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 12 – August 21, 2000 Issue
Bio-Reference Laboratories, Inc. (BRLI) announced that its physician Web portal service, CareEvolve.com, gained 200 enrolled physicians in the first eight days following its August 1, 2000 release. As a laboratory company, BRLI recognizes that its physician network is the real asset …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized